← Insider buys

Yann Mazabraud has sold RYTM and made no open-market buys since Feb 2023

EVP, Head of International at Rhythm Pharmaceuticals, Inc.

SEC CIK 0001774702 · Filings on SEC.gov ↗

$0Bought
$7.5MSold
NoneLast buy

Every filing

5 filings since Feb 2023, newest first

Filings come from SEC EDGAR. Not investment advice.